Concord Biotech Q3 Results

  • BSE: 543960
  • NSE: CONCORDBIO
  • ISIN: INE338H01029
  • Sector: -
BSE
2,073.341.75 (2.06%)
Volume8.86 K
Updated: Mon 25 Nov, 2024 | 15:29:42
NSE
2,06949.70 (2.46%)
Volume1.66 L
Updated: Mon 25 Nov, 2024 | 15:30:03
Today: 2,002.20
2,099.95
52-Wk: 1,206.00
2,658.00

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Concord Biotech Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ Comp
    Total Revenue 240.80262.35-%
    Selling/ General/ Admin Expenses Total 30.6730.17-%
    Depreciation/ Amortization 13.5413.30-%
    Other Operating Expenses Total 57.1160.12-%
    Total Operating Expense 148.40156.45-%
    Operating Income 92.39105.89-%
    Net Income Before Taxes 103.10109.70-%
    Net Income 77.5781.02-%
    Diluted Normalized EPS 7.417.74-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts